Teva Continues Restructuring With 46 Cuts in Pennsylvania Post author:Sam Post published:February 7, 2018 Post category:BioPharma The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace You Might Also Like Interpace Diagnostics Announces Coverage Of Thyroid Test By August 15, 2017 Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran November 19, 2017 bluebird bio Touts Impressive Data From Late-Stage Gene Therapy Study June 22, 2017